C65 -Malignant neoplasm of renal pelvis
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C65 – N =3,032
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 19.3% | 22.7% | 13.4% | 23.5% | 21% | 119 |
1996 | 19.2% | 26% | 12.5% | 13.5% | 28.8% | 104 |
1997 | 14.9% | 16% | 18.1% | 22.3% | 28.7% | 94 |
1998 | 18.7% | 13.7% | 18.7% | 18% | 30.9% | 139 |
1999 | 12.2% | 15.5% | 23% | 18.9% | 30.4% | 148 |
2000 | 21% | 17.7% | 12.9% | 20.2% | 28.2% | 124 |
2001 | 22.2% | 13.9% | 20.8% | 23.6% | 19.4% | 144 |
2002 | 20.3% | 16.5% | 21.5% | 17.1% | 24.7% | 158 |
2003 | 25% | 13.2% | 23.5% | 18.4% | 19.9% | 136 |
2004 | 27.5% | 8.7% | 15.2% | 22.5% | 26.1% | 138 |
2005 | 25.8% | 13.5% | 19.6% | 22.1% | 19% | 163 |
2006 | 24.8% | 11.5% | 20% | 27.9% | 15.8% | 165 |
2007 | 26.1% | 5.6% | 22.4% | 32.3% | 13.7% | 161 |
2008 | 29% | 10.1% | 27.2% | 26.6% | 7.1% | 169 |
2009 | 21.7% | 12.7% | 25.9% | 30.7% | 9% | 166 |
2010 | 27.5% | 15.6% | 25% | 26.9% | 5% | 160 |
2011 | 28% | 10.8% | 17.8% | 24.8% | 18.5% | 157 |
2012 | 22.4% | 11% | 17.1% | 25.2% | 24.3% | 210 |
2013 | 27% | 8.2% | 17.9% | 34.7% | 12.2% | 196 |
2014 | 28.2% | 13.8% | 26.5% | 26% | 5.5% | 181 |